- Home
- INLF vs ALLR Comparison
INLF vs ALLR Comparison
Compare INLF & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLF
- ALLR
- Stock Information
- Founded
- INLF 2016
- ALLR 2004
- Country
- INLF China
- ALLR United States
- Employees
- INLF N/A
- ALLR N/A
- Industry
- INLF Industrial Machinery/Components
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- INLF Industrials
- ALLR Health Care
- Exchange
- INLF Nasdaq
- ALLR Nasdaq
- Market Cap
- INLF 16.2M
- ALLR 15.8M
- IPO Year
- INLF 2025
- ALLR N/A
- Fundamental
- Price
- INLF $1.09
- ALLR $1.01
- Analyst Decision
- INLF
- ALLR Strong Buy
- Analyst Count
- INLF 0
- ALLR 1
- Target Price
- INLF N/A
- ALLR $9.00
- AVG Volume (30 Days)
- INLF 148.4K
- ALLR 536.3K
- Earning Date
- INLF 01-01-0001
- ALLR 08-08-2025
- Dividend Yield
- INLF N/A
- ALLR N/A
- EPS Growth
- INLF 18.78
- ALLR N/A
- EPS
- INLF 0.13
- ALLR N/A
- Revenue
- INLF $15,796,983.00
- ALLR N/A
- Revenue This Year
- INLF N/A
- ALLR N/A
- Revenue Next Year
- INLF N/A
- ALLR N/A
- P/E Ratio
- INLF $8.48
- ALLR N/A
- Revenue Growth
- INLF 25.27
- ALLR N/A
- 52 Week Low
- INLF $0.77
- ALLR $0.61
- 52 Week High
- INLF $21.00
- ALLR $6.00
- Technical
- Relative Strength Index (RSI)
- INLF N/A
- ALLR 49.17
- Support Level
- INLF N/A
- ALLR $1.03
- Resistance Level
- INLF N/A
- ALLR $1.17
- Average True Range (ATR)
- INLF 0.00
- ALLR 0.08
- MACD
- INLF 0.00
- ALLR -0.00
- Stochastic Oscillator
- INLF 0.00
- ALLR 28.89
About INLF INLIF LIMITED Ordinary Shares
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.